Vaccine
Inovio posts “exceptional” results for HIV vaccine
May 25, 2017Research and Development AIDS, HIV, HIV vaccine, Vaccine
Inovio Pharmaceuticals has been working on HIV vaccines for a long time and, eight years after signing a $25 million …
Brazil declares end to Zika virus emergency
May 12, 2017Medical Communications Brazil, Vaccine, Zika, Zika virus
Brazil has declared that the national emergency over the Zika virus threat is over, after there was a 95% drop …
Malaria vaccine displays 100% success rate in clinical trial
February 16, 2017Research and Development Vaccine, malaria
A malaria vaccine, jointly developed by the University of Tübingen and biotech company Sanaria Inc., has demonstrated in a small pool …
African Heads of State commit to universal access to immunisation
February 1, 2017Medical Communications, Research and Development Africa, Vaccine, WHO, immunisation
The Heads of State convened from across Africa to ratify the Addis Declaration on Immunization (ADI). The pledge commits to …
Philippine FDA orders Sanofi to pull dengue vaccine ads
January 5, 2017Medical Communications, Sales and Marketing Philippines, Sanofi, Vaccine, dengue, virus
Sanofi has suffered a major blow to its dengue immunisation programme in the Philippines after it was requested the company …
FDA approves clinical trial of Cuban lung cancer vaccine
November 1, 2016Manufacturing and Production, Sales and Marketing Cuba, US, Vaccine, cimavax, clinical trials
The thawing of relations between the US and Cuba has allowed a pioneering treatment for non-small cell lung cancer to …
GSK applies for FDA approval for shingles vaccine
October 24, 2016Sales and Marketing GSK, GlaxoSmithKline, Vaccine, chickenpox, shingles
GlaxoSmithKlien, the UK’s biggest drugmaker, is seeking approval from the FDA for a shingles (herpes zoster) vaccine. The vaccine would …
Sun Pharma partners with ICGEB to develop dengue vaccine
October 19, 2016Research and Development Vaccine, dengue, icgeb, sun pharmaceutical
Indian drug firm Sun Pharma is set to join forces with the International Centre for Generic Engineering and Biotechnology (ICGEB) …
Kymab demonstrates promising research for HIV vaccine development
September 9, 2016Medical Communications, Research and Development HIV, Vaccine, kymab
Cambridge-based antibodies-to-medicines company Kymab has announced publication of research testing the first step in the effort to develop effective vaccines …
Takeda begins Phase III dengue vaccine trial
September 8, 2016Research and Development Takeda, Vaccine, dengue, dengue vaccine, phase III, trial
Takeda Pharmaceuticals has announced the initiation of a global Phase III clinical trial to test its live-attenuated tetravalent dengue vaccine …
Sanofi launches dengue immunisation program in Brazil
August 15, 2016Research and Development, Sales and Marketing Brazil, Sanofi, Sanofi Pasteur, Vaccine, dengue, immunisation, vaccines
Sanofi has announced that it has initiated the first dengue immunisation public program in the Americas, with 500,000 individuals set …
NIH launches test of investigational human Zika vaccine
August 4, 2016Research and Development Vaccine, Zika virus
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has begun the clinical …
MHRA approves Sanofi Pasteur MSD’s four-strain influenza vaccine for UK use
July 25, 2016Manufacturing and Production, Research and Development, Sales and Marketing MHRA, Sanofi pasteur msd, UK, Vaccine, flu, influenza
Sanofi Pasteur MSD has announced the approval of the latest addition to its family of influenza vaccines in the UK: …
Sanofi says to co-develop Zika vaccine with US government
July 6, 2016Research and Development, Sales and Marketing Sanofi, US government, Vaccine, Zika virus, drug development, research
French drugmaker Sanofi (Euronext: SAN) said it will co-develop a Zika vaccine candidate with the US government. No financial details …
Takeda begins world’s first norovirus vaccine field trial
June 22, 2016Research and Development Takeda, Vaccine, norovirus
Takeda Pharmaceuticals (TSE: 4502) has announced that the first patient has received a dosage of their norovirus vaccine candidate, TAK-214, …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
